Table II.
Group | Clinical response | No. of patients |
---|---|---|
Responder | ||
CR | 2 | |
PR | 13 | |
Non-responder | ||
MR | 4 | |
NC | 12 | |
PD | 11 | |
Total | 42 |
Responder group, CR or PR; non-responder group, PD, NC or MR. CR, complete response (shrinkage rate 100%); PR, partial response (shrinkage rate ≥50 to <100%); MR, minor response (shrinkage rate ≥25 to <50%); NC, no change (shrinkage rate ≥−25 to <25%); PD, progressive disease (shrinkage rate ≤−25%). Shrinkage rate, tumor shrinkage rate in pulmonary metastasis. Efficacy rate 35.7%.